Endomag operates as a medical device company designed to detect breast cancer. The Company offers: Sentimag, an instrument for ultrasensitive detection in pre-and post-incision use for a range of hospitals and clinics; Sienna, a tracer that produces a transient magnetic response; Magseed to guide surgeons using Sentimag during a breast lumpectomy; Magtrace, a non-radioactive dual-tracer for lymphatic mapping in patients with breast cancer undergoing a mastectomy; and Siennova, a therapeutic hyperthermia system used as an adjuvant to chemo- and radiotherapy.
|Employees (est.) (Feb 2019)||23||(+5%)|
Endomag total Funding
Endomag latest funding size
Time since last funding
|7 months ago|
|Sussex Place Ventures, UCLB, New Wave Ventures, Sarum Partners, Bloomsbury Bioseed Fund, Draper Esprit|
Endomag has 774 Twitter Followers. The number of followers has increased 0.7% month over month and increased 3.6% quarter over quarter
When was Endomag founded?
Endomag was founded in 2007.
Who are Endomag key executives?
Endomag's key executives are John Gonzalez and Eric Mayes.
How many employees does Endomag have?
Endomag has 23 employees.
Who are Endomag competitors?
Competitors of Endomag include E-Qure, Obalon Therapeutics and SetPoint Medical.
Where is Endomag headquarters?
Endomag headquarters is located at Milton Road, Milton.
Where are Endomag offices?
Endomag has offices in Milton and Austin.
How many offices does Endomag have?
Endomag has 2 offices.